Triglycerides – a Strong Predictor of CV Events
The increasing prevalence of obesity is directly associated with the increase in type 2 diabetes (T2D) and metabolic syndrome (MS), which, in turn, are associated with lipoprotein abnormalities described as atherogenic dyslipidaemia (AD). AD is causally linked to the development and progression of atherosclerotic CV disease (ASCVD).
Modern Medicine – Issue 6 2022
